95 related articles for article (PubMed ID: 9208870)
21. Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes.
Nyman TA; Tölö H; Parkkinen J; Kalkkinen N
Biochem J; 1998 Jan; 329 ( Pt 2)(Pt 2):295-302. PubMed ID: 9425112
[TBL] [Abstract][Full Text] [Related]
22. Characterization and humanization of a monoclonal antibody that neutralizes human leukocyte interferon: a candidate therapeutic for IDDM and SLE.
Chuntharapai A; Lai J; Huang X; Gibbs V; Kim KJ; Presta LG; Stewart TA
Cytokine; 2001 Sep; 15(5):250-60. PubMed ID: 11594789
[TBL] [Abstract][Full Text] [Related]
23. The human interferon system: characterization and classification after discovery of novel members.
Kontsek P; Karayianni-Vasconcelos G; Kontseková E
Acta Virol; 2003; 47(4):201-15. PubMed ID: 15068375
[TBL] [Abstract][Full Text] [Related]
24. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
25. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.
Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I
Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004
[TBL] [Abstract][Full Text] [Related]
26. Shrimp interferon is rather a portion of the mitochondrial F0-ATP synthase than a true alpha-interferon.
Rosa RD; Barracco MA
Mol Immunol; 2008 Jul; 45(12):3490-3. PubMed ID: 18533263
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha 2 produced by normal human leukocytes is predominantly interferon-alpha 2b.
Dipaola M; Smith T; Ferencz-Biro K; Liao MJ; Testa D
J Interferon Res; 1994 Dec; 14(6):325-32. PubMed ID: 7897251
[TBL] [Abstract][Full Text] [Related]
28. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
[TBL] [Abstract][Full Text] [Related]
29. Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy.
Chayama K; Suzuki F; Tsubota A; Kobayashi M; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Takahashi N; Kinoshita M; Kumada H
Hepatology; 2000 Nov; 32(5):1138-44. PubMed ID: 11050067
[TBL] [Abstract][Full Text] [Related]
30. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
31. Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide.
Sancéau J; Poupon MF; Delattre O; Sastre-Garau X; Wietzerbin J
Oncogene; 2002 Oct; 21(50):7700-9. PubMed ID: 12400012
[TBL] [Abstract][Full Text] [Related]
32. High-yield expression and purification of human interferon alpha-1 in Pichia pastoris.
Liu PT; Ta TV; Villarete LH
Protein Expr Purif; 2001 Aug; 22(3):381-7. PubMed ID: 11482999
[TBL] [Abstract][Full Text] [Related]
33. A Low-Molecular-Weight Compound Derived from Human Leukocytes Determines a Bactericidal Activity of the Interferon Preparation.
Vasilchenko AS; Gritsenko VA; Kosyan DB; Rogozhin EA
Probiotics Antimicrob Proteins; 2019 Sep; 11(3):999-1008. PubMed ID: 30215182
[TBL] [Abstract][Full Text] [Related]
34. Betaseron.
Lin L
Dev Biol Stand; 1998; 96():97-104. PubMed ID: 9890522
[TBL] [Abstract][Full Text] [Related]
35. Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists.
Pan M; Kalie E; Scaglione BJ; Raveche ES; Schreiber G; Langer JA
Biochemistry; 2008 Nov; 47(46):12018-27. PubMed ID: 18937499
[TBL] [Abstract][Full Text] [Related]
36. Capillary electrophoretic separation of high-molecular-weight poly(ethylene glycol)-modified proteins.
Na DH; Park EJ; Jo YW; Lee KC
Anal Biochem; 2008 Feb; 373(2):207-12. PubMed ID: 17888863
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to equine interferon-alpha (IFN-alpha): new tools to neutralize IFN-activity and to detect secreted IFN-alpha.
Wagner B; Hillegas JM; Flaminio MJ; Wattrang E
Vet Immunol Immunopathol; 2008 Oct; 125(3-4):315-25. PubMed ID: 18586327
[TBL] [Abstract][Full Text] [Related]
38. Conservation of leukocyte cell surface proteins: implications for the generation of monoclonal antibodies against newly identified leukocyte cell surface proteins.
Zola H; Mavrangelos C; Millard DJ; Nicholson IC
Tissue Antigens; 2006 Jul; 68(1):13-8. PubMed ID: 16774535
[TBL] [Abstract][Full Text] [Related]
39. Novel interferon delta genes in mammals: cloning of one gene from the sheep, two genes expressed by the horse conceptus and discovery of related sequences in several taxa by genomic database screening.
Cochet M; Vaiman D; Lefèvre F
Gene; 2009 Mar; 433(1-2):88-99. PubMed ID: 19110041
[TBL] [Abstract][Full Text] [Related]
40. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
